Lenvima and Vincristine liposome Intravenous

• Generic Name: lenvatinib
• Dosage Forms: capsule
• Other Brand Names: Lenvima, Lenvima 8 mg daily-dose, Lenvima 20 mg daily-dose, Lenvima 12 mg daily-dose

Lenvima (lenvatinib) is a cancer medicine that interferes with the growth and spread of cancer cells in the body.

Lenvima is used to treat thyroid cancer. It is usually given after radioactive iodine has been tried without success.

Lenvima is used together with everolimus (Afinitor) to treat advanced kidney cancer when other medicines have not been effective.

Lenvima is used alone to treat liver cancer that cannot be removed with surgery.

Lenvima is used together with pembrolizumab (Keytruda) to treat a certain type of endometrial cancer (a type of uterine cancer) that has progressed and cannot be removed with surgery or radiation.

• Generic Name: vincristine liposome
• Dosage Forms: n.a.
• Other Brand Names: Marqibo

Vincristine liposome injection is used to treat Philadelphia chromosome-negative acute lymphoblastic leukemia (Ph- ALL) in adult patients who have received at least 2 prior treatments that did not work well. It interferes with the growth of cancer cells, which are eventually destroyed by the body. Vincristine liposome is an antineoplastic agent (cancer medicine).

Vincristine liposome is only administered by or under the supervision of your doctor.